Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001209191-17-046876)

Filing Details

Accession Number:: 0001209191-17-046876
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2017-08-01 13:43:21
Reporting Period:: 2017-08-01

Filing Date:: 2017-08-01
Accepted Time:: 2017-08-01 13:43:21
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1358762	Reata Pharmaceuticals Inc	RETA	Pharmaceutical Preparations (2834)	113651945

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1662321	Edward James Bass	2801 Gateway Drive Suite 150 Irving TX 75063		Yes	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Class A Common Stock	Acquisiton	2017-08-01	8,064	$31.00	67,411	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Class A Common Stock	41,902	Indirect	By Bass Family Trust A
Class A Common Stock	17,555	Indirect	By Bass Trust FBO James E. Bass

Footnotes

Due to the conditions to closing of the public offering of the Class A common stock, these purchases were not deemed to occur until closing, on August 1, 2017.